CAW
IMMU

Cornerstone Advisors (Washington)’s Immunomedics Inc IMMU Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$186K Sell
2,185
-719
-25% -$36.4K 0.02% 112
2020
Q2 		$103K Hold
2,904
– – 0.01% 166
2020
Q1 		$39K Hold
2,904
– – 0.01% 251
2019
Q4 		$61K Buy
2,904
+805
+38% +$14.2K 0.01% 208
2019
Q3 		$28K Hold
2,099
– – ﹤0.01% 296
2019
Q2 		$29K Hold
2,099
– – ﹤0.01% 566
2019
Q1 		$40K Buy
+2,099
New +$33.8K ﹤0.01% 434

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Cornerstone Advisors (Washington)'s IMMU Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Immunomedics Inc (IMMU) stake by 25% in Q3 2020, selling an estimated $36.4K and leaving 2,185 shares worth $186K. The position accounts for 0.02% of the portfolio, ranked #112.

Cornerstone Advisors (Washington) first reported a position in IMMU in Q1 2019 and has held it in 7 quarters since. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Cornerstone Advisors (Washington) held 2,185 shares of Immunomedics Inc worth $186K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 719 Immunomedics Inc shares in Q3 2020, an estimated $36.4K.
  • Immunomedics Inc made up 0.02% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #112 holding.
  • Cornerstone Advisors (Washington) first reported a position in Immunomedics Inc in Q1 2019 and has held it in 7 quarters since.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.